Antifracture Efficacy of 5- or 10-Yearly Zoledronate in Women Aged 50 to 60 Years: Secondary Analyses of a Randomized Trial - Top-Institutions - MDSpire

Antifracture Efficacy of 5- or 10-Yearly Zoledronate in Women Aged 50 to 60 Years: Secondary Analyses of a Randomized Trial

  • By

  • Mark J Bolland

  • Zaynah Nisa

  • Anna Mellar

  • Chiara Gasteiger

  • Veronica Pinel

  • Borislav Mihov

  • Sonja Bastin

  • Andrew Grey

  • Ian R Reid

  • Greg Gamble

  • Anne Horne

  • October 18, 2025

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Osteoporosis
    • Endocrinology
    • Clinical Research
  • #2

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Endocrinology
    • Osteoporosis
    • Clinical Trials
  • #3

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Osteoporosis
    • Rheumatology
    • Bone Metabolism
  • #4

    University of Oxford, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences
    University of Oxford, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences

    Oxford, UK

    Key Differentiators

    • Osteoporosis
    • Musculoskeletal Research
    • Clinical Epidemiology
  • #5

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Endocrinology
    • Osteoporosis
    • Clinical Research

Original Source(s)

Related Content